Research and Development

Gilead has announced that Dr Norbert Bischofberger, its Chief Scientific Officer (CSO), Executive Vice President of Research and Development and …

A male contraceptive pill may be edging closer to the market, after a new formulation was shown to be safe …

Merck KGaA’s Chris Round, Head of EMEA Region, spoke with Pharmafile.com to discuss his time at both the US and …

A new stem cell transplant is being hailed as a “game-changer” in the treatment of multiple sclerosis (MS) after an …

Another week goes by, and we may have finally reached Spring here in the UK. Friday means its time for …

Biotechs with few products in the portfolio are always at a risk should results come back flat, it often leads …

Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal …

Solid Biosciences raised more than a few eyebrows when it only revealed a partial hold from the FDA stalling its …

Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due …

Takeda has announced that its Chief Financial Officer, James Kehoe, has decided to move on from the company to take …

Teva has denied allegations from the European Commission (EC) that it engaged in illegal anti-competitive pay-to-delay tactics to maintain its …

The pressures on the NHS over the winter months exposed serious cracks in the service, with issues regarding underfunding, struggles …

The divisive and much-talked-about “right to try” legislation designed to provide access for terminally ill Americans to experimental and unproven …

One of the major challenges in delivering vaccinations to all parts of the globe is the need to keep the …

AbbVie’s elagolix has been slated as a blockbuster-in-the-making by analysts predicting big things for the potential treatment for uterine fibroids …